Several considerations in using traditional Chinese patent medicine for cerebral infarction / 中国结合医学杂志
Chinese journal of integrative medicine
;
(12): 571-574, 2012.
Artigo
em Inglês
| WPRIM
| ID: wpr-347151
ABSTRACT
Nowadays, a great number of traditional Chinese patent medicine (TCPM) are used more and more widely to treat cerebral infarction in China. When great attention is paid to using TCPM in the real world, several problems can be identified ignoring the Chinese medicine (CM) therapeutic principle based on syndrome differentiation, a lack of appropriate dosage and usage based on individual patient conditions, and a shortage of evidence from randomized, double-blind, placebo-controlled clinical trials. Furthermore, in terms of evaluation of the TCPM effectiveness, few comprehensive criteria and evaluation methods recognized by the international community exist. This article addresses some opinions regarding the above mentioned problems.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Patentes como Assunto
/
Medicamentos de Ervas Chinesas
/
Infarto Cerebral
/
Usos Terapêuticos
/
Relação Dose-Resposta a Droga
/
Tratamento Farmacológico
/
Medicina Tradicional Chinesa
Tipo de estudo:
Ensaio Clínico Controlado
/
Estudo diagnóstico
/
Estudo prognóstico
Limite:
Animais
/
Humanos
Idioma:
Inglês
Revista:
Chinese journal of integrative medicine
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS